Scientific Research Team

The Scientific Research Team at Ambagon Therapeutics focuses on discovering and developing small molecule cancer drugs that target and stabilize interactions between oncogenic proteins and the 14-3-3 class of adaptor proteins. This team conducts structural biology research, biochemistry assays, proteomics analysis, and bioinformatics to identify and optimize potential drug candidates. Collaboration among scientists, research associates, and directors ensures the integration of cutting-edge research techniques to advance therapeutic discoveries.